Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation
- 27 March 2000
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (7) , 723-728
- https://doi.org/10.1038/sj.bmt.1702194
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 23 references indexed in Scilit:
- Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?Bone Marrow Transplantation, 1999
- Oligoclonal Protein Bands and Ig Isotype Switching in Multiple Myeloma Treated With High-Dose Therapy and Hematopoietic Cell TransplantationBlood, 1998
- Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literatureBone Marrow Transplantation, 1997
- Comparative study of peripheral blood progenitor cell collection in patients with multiple myeloma after single‐dose cyclophosphamide combined with rhGM‐CSF or rhG‐CSFBritish Journal of Haematology, 1995
- Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patientsBlood, 1995
- The Treatment of Multiple MyelomaNew England Journal of Medicine, 1994
- PROSPECTIVE STUDY OF THE OCCURRENCE OF MONOCLONAL GAMMAPATHIES FOLLOWING BONE MARROW TRANSPLANTATION IN YOUNG CHILDRENTransplantation, 1990
- Divergent effects of interleukin-4 (IL-4) on the granulocyte colony- stimulating factor and IL-3-supported myeloid colony formation from normal and leukemic bone marrow cellsBlood, 1990
- FREQUENT OCCURRENCE OF MONOCLONAL GAMMOPATHIES WITH AN IMBALANCED LIGHT-CHAIN RATIO FOLLOWING BONE MARROW TRANSPLANTATIONTransplantation, 1987
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975